Estrogen + progestin therapy
Estrogen + progestin therapy has been studied in 4 papers since 2021: none in people yet, 4 reviews. No study of it in people or animals has been published yet. The newest paper, Sep 26, 2024: “Menopause and endometriosis”.
4 papers study it2 findingsUpdated
See all 4 papers on estrogen + progestin therapy
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Meta-analyses suggested a small increased AD risk after 5-10 years prescription of combination MHT regardless of age”
- 1 lab in 1 country
What is estrogen + progestin therapy linked with?
2Studies link estrogen + progestin therapy with 2 measures, most often Alzheimer's disease (1 study) and breast cancer (1).
Alzheimer's disease
upin humans1
1 study
Alzheimer's disease
upin humans1
Estrogen + progestin therapy is linked with a higher risk of Alzheimer's disease in humans (prescription of combination MHT regardless of age).
“Meta-analyses suggested a small increased AD risk after 5-10 years prescription of combination MHT regardless of age”
Humansprescription of combination MHT regardless of age5-10 yearsfemales
Journal of Alzheimer's disease : JAD
Breast cancer
upin humans1OR 1.14–2.38
1 study
Breast cancer
upin humans1OR 1.14–2.38
Estrogen + progestin therapy raises the risk of breast cancer in humans (OR 1.14- 2.38).
“use of estrogen in combination with progestogens, depending on the type of progestogens, shows an increased risk of breast cancer”
Reviewin combination with progestogens3 to 5 yearsfemales
Progestins and the Risk of Breast Cancer
Acta endocrinologica (Bucharest, Romania : 2005)